Relapsed/Refractory Multiple Myeloma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics:

Multiple Myeloma (0:00)Introduction: ESMO 2026; Recent FDA Approvals (1:53)Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial (2:46)Bispecific Antibodies — Dr Lonial (19:16)Antibody-Drug Conjugates — Dr Richardson (37:08)Up-Front Treatment; Cereblon E3 Ligase Modulators — Dr Richardson (50:10)

CME information and select publications